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Ambulation with a walker during complex path configurations induces a higher attentional
cost for persons with Alzheimer’s disease

ABSTRACT
Ambulation with a mobility aid is a unique real-life situation of multi-tasking. These
simultaneous motor tasks place increased demands on executive function in healthy young and
older adults, but the demands have not been evaluated in people with Alzheimer’s disease (AD).
Mobility problems are common among adults with AD, leading to provision of a mobility aid to
optimize independent activity. The study objectives were: i) to determine the dual-task cost
(DTC) associated with the use of a mobility aid in straight and complex path walking, and ii) to
evaluate the association between executive function and ambulation with a mobility aid in older
adults with AD and age-sex matched cognitively normal controls. Fourteen people (mean
age±SD, 72.6±9.9 years) with a diagnosis of probable AD (MMSE range 12-25) and controls
(mean age±SD, 72.9±9.5) walked at a self-selected pace and using a 4-wheeled walker in a 6
meter straight path and a Figure of 8 Test. Ambulation with the walker in a straight path
produced a low DTC that was not different between the groups. Ambulation with the 4-wheeled
walker in the complex path produced a significantly different DTC in the group with AD at 38.1±23.5% compared to -19.7±21.4% (p=0.041). Lower scores on executive function were
associated with longer times across test conditions. Ambulation with a 4-wheeled walker, in
particular maneuvering around obstacles, requires greater attentional costs in dementia. Future
research should explore the timing for safely introducing mobility aids in AD and the role of
improving executive function.

INTRODUCTION
Falls among older adults are a significant public health problem and have substantial
consequences on an individual’s quality of life and independence. An emerging area of falls
research is the role of cognition in postural stability; a timely focus as the prevalence of
dementia, and its attendant increased health care needs and utilization, is expected to increase
dramatically in coming years.[1]
Ambulation with a mobility aid is a unique real-life situation of multi-tasking; the
performance of these simultaneous motor tasks places increased demands on brain resources
related to executive function.[2] Executive function, which comprises the set of cognitive
processes that use sensory information to modulate behavior, is required for planning
movements, dividing attention, and responding to changes in the environment.[3] Increased
attentional demands have been observed in healthy young adults[4] and older adults[5] using
mobility aids suggesting that executive resources are necessary for their proper use. The use of a
mobility aid requires high levels of motor control and may challenge cognitive function to
generate responsive motor patterns to multiple sensory inputs and environmental conditions.[2]
Decreased executive function is an early symptom in Alzheimer’s disease (AD)[6] and a
proven risk factor for falls[7]. In addition, gait and mobility impairments are common features in
community-dwelling older adults living with dementia.[8] Older adults with cognitive
impairment demonstrate decreased gait velocity and increased gait instability while multitasking, which are also associated with an elevated fall risk.[9] Rehabilitation interventions to
reduce risk can include individualized exercise programs and the prescription of a mobility aid to
compensate for deficits and allow maintenance of independent ambulation.
The use of a mobility aid is also associated with an elevated fall risk in older adults.[10]
Mobility aid use could be a proxy for the presence of intrinsic functional limitations, such as
balance or gait problems; but, the elevated risk remains even when those factors have been taken
into account.[10] Additional considerations that would link mobility aid use to an elevated fall
risk include interference with lower extremity movement during balance recovery to a
perturbation, it prevents the use a person’s hands to effectively reach for support when there is a
loss of balance and it increases cognitive demands related to attentional processing and
neuromotor control.[2]
Observing people during a gait or balance task while they perform a secondary task (the
dual-task paradigm) is an accepted way to assess the interaction between cognition and
mobility.[11] Cognitive demands relative to the cognitive capacity or reserve of the individual
influence physical task performance. If the demands of executing two tasks simultaneously
exceed the cognitive capacity, then overall performance will be degraded.[12] The configuration
of the walking pattern in the dual task testing protocol is also relevant in the evaluation of
functional abilities. Gait performance under a straight path condition is considered a low
challenge activity, while curved or complex path walking can provide meaningful information
about daily life walking ability, including adaptation of walking patterns to negotiate obstacles,
change directions, or plan a path.[13]
There has been no research evaluating the “cost” on gait performance of using a mobility
aid in older adults with dementia. Moreover, whether the use of assistive devices generates a
“cognitive cost” on gait performance in older adults with AD is unknown though it is
hypothesized that ambulation with a mobility aid for people with dementia will be associated
with a high attentional load. We hypothesized the use of a mobility aid in older adults with AD

will adversely affect gait performance and be most affected under the test condition of walking
with a mobility aid on a curved path test condition. The study objectives were: i) to determine the
dual-task cost associated with the use of a mobility aid in straight path and complex path walking
in older adults with Alzheimer disease and age-sex matched cognitively normal controls, and ii)
to evaluate the association between executive function and the functional performance on
ambulation with a mobility aid.
METHODS
Study subjects
A convenience sample of adults with a diagnosis of mild to moderate Alzheimer’s
disease was recruited from a day program for community-dwelling older adults with dementia.
Referral to the day program is based on a confirmed diagnosis of dementia by a geriatrician
according to the criteria of the National Institute of Neurologic and Communicative Disorders
and Stroke-AD and Related Disorders Association (NINCDS-ARDRA).[14] Inclusion criteria:
age greater than 50 years, medically stable, English speaking, no physical impairments that
would necessitate use of a mobility aid, had not used a walker previously and able to understand
simple instructions. People were excluded if they had any neurological, musculoskeletal, or
cardiorespiratory impairment that could compromise safe administration of the testing protocol.
All participants or their caregivers provided written informed consent prior to participation in the
study.
Control participants were recruited by newspaper advertisement and from a community
fitness program. The inclusion criteria for the control group were: no subjective memory
complaints, normal performance on cognitive tests, absence of functional impairment, and ability
to walk independently. The control participants were matched to the participants with dementia
on sex and age, plus or minus 2 years. This study was approved by the _____________ Research
Ethics Board for Health Sciences Research Involving Human Subjects.
Medical and Cognitive Assessments
Sociodemographic information, co-morbidities, physical activity level, activities of daily
living (instrumental and basic), Falls Efficacy Scale-International[15] and medications were
recorded. Cognition was assessed using the Mini-Mental State Examination[16] (MMSE; score
0–30). The severity of dementia was categorized according to the MMSE score: mild dementia,
MMSE > 20 points; moderate dementia, MMSE = 10-20 points; and severe dementia, MMSE <
10 points. Executive function was measured using the Trail Making Test[17] (TMT). The TMT
has two parts: Part A (TMT-A) requires participants to draw lines sequentially connecting 25
numbers, and Part B (TMT-B) requires them to draw lines sequentially alternating between
numbers and letters (e.g., 1, A, 2, B, . . .). The TMT assesses visual search ability, scanning,
speed of processing, mental flexibility, and executive functioning.[18] Results are reported as the
time in seconds required to complete the task; a longer completion time indicates greater
impairment. The TMT is sensitive to a variety of neurological impairments and processes.[18]
Gait Assessment
In the straight path walking, participants were timed while walking at a self-selected
usual speed for a 6 meter distance, with one meter at either end to allow for acceleration and
deceleration. In the complex path walking, the Figure 8 Walk Test[19] protocol will be used and
reliability for this test has been demonstrated in older adults with dementia.[20] Participants start
in standing, midway between two cones placed 1.52 meters apart and walk in a figure-of-8 path
around the cones. The total time and the number of steps was recorded. The dual-task test

condition required the person to perform both walking configurations using a four wheeled
walker.
Sample size. Based on previous data from our research in people with dementia (dual-task cost:
15% in cognitively normal older adults, 38% in older adults with dementia)[9], a sample size of
12 participants was needed for a power of 80% with α error of 5% to detect a 15% difference in
dual-task cost.
Data analysis: Baseline characteristics of demographic and mobility variables were calculated as
means and SDs or frequencies and percentages, as appropriate. For the first objective, a two-way
repeated measures ANOVA using a general linear model evaluated the time to complete each
walk in each configuration and the number of steps in the complex path (3 models). When
interactions were non-significant main effects were assessed. The dual-task cost percentage for
time to complete the straight path and complex path, and the number of steps in the complex path
were evaluated with unpaired t-tests between the controls and the people with AD. The dual-task
cost (DTC), as a percentage, was calculated as [(single task value − dual task value) / single task
value] × 100% for each walking condition, straight and curved path walking, under single and
walking with the wheeled walker and the number of steps to complete the complex path with a
walker for each group. A negative DTC indicates that gait performance was decreased under the
condition of using the wheeled walker. For the secondary objective, linear regression analyses
between executive function (Trail Making Test B) and the time to complete each walking test in
each test configuration were performed (4 separate models). All statistical analyses were
performed using SPSS version 23.0 (SPSS, Inc., Chicago, IL) with statistical significance set at p
< 0.05.
RESULTS
Fourteen people with mild to moderate Alzheimer’s disease and controls were recruited
for the study. Analysis of demographic characteristics demonstrated differences between the two
groups on cognitive function and physical activity (Table 1). The differences between groups on
cognition were expected as this defines membership in each group. Also there was a difference
in the performance of instrumental and basic activities of daily living, the controls demonstrating
no deficits and the people with AD possessing deficits in both domains, greater in instrumental
activities consistent with the diagnosis of dementia. Physical activity levels also differed
significantly between the groups, though a fear of falling and a history of falls were not different.
In the straight path condition, only the main effect of group was significant. People with
AD walked slower than the controls in the single task (p=0.021) and using a wheeled walker
(p=0.020). In the complex path condition, the interaction of group x task was statistically
significant for time (p<0.001) and number of steps (p<0.001). (Figure 1 and 2)
The DTC was not different between the controls and people with AD for the wheeled
walker task (-0.53±10.14% versus -4.64±11.47%, p=0.324) under the straight path condition. In
the complex path condition, the DTC was significantly different between people with AD and
controls for the wheeled walker task (-38.1±23.5% versus -19.7±21.4%, p=0.041) indicating
greater cognitive load in the people with Alzheimer’s disease. The dual-task cost for the number
of steps was also significant (-16.85±17.91% versus -34.20±19.61%, p=0.022).
The linear regression demonstrated that executive function was significantly related to
the time to complete all walking tasks; longer times to complete the TMT-B were associated
with longer times to complete the walking tests. (Figure 3) The unstandardized regression
coefficients for the TMT-B were: simple path usual gait, β=0.006(0.003-0.01), p=0.001,

R2=0.373; simple path with walker, β=0.008(0.003-0.013), p=0.002, R2=0.352; complex path
usual gait, β=0.019(0.007-0.032), p=0.001, R2=0.291; and complex path with walker,
β=0.024(0.010-0.037), p=0.001, R2=0.346. The regression coefficient represents the amount of
change in time, in seconds, to complete the walking test that is associated with each second
increase in time to complete the TMT-B.
DISCUSSION
This study has demonstrated that ambulating with a walker in a complex pattern
generates a significantly higher cognitive load in people with AD, as demonstrated by a larger
dual-task cost compared to healthy controls. Our finding is consistent with previous research that
has demonstrated an increased cognitive load with use of a walker in healthy younger and older
adults[2,4,5]; and, to the best of our knowledge, this study is one of the first to show that people
with dementia experience an even greater demand on already limited or fragile cognitive
resources. This finding has important clinical implications for fall prevention strategies and
mobility aid prescription among people with AD.
Interestingly, the time to complete the straight path with the wheeled walker was no
different than the single-task activity of usual gait speed for either group. This highlights the
importance of the test configuration for dual-task testing to detect deficits as a straight path is
considered a low challenge scenario.[13,22] This study supports that even in people with mild to
moderate AD this is a low challenge activity and does not represent real world situations that are
encountered while using a wheeled walker, such as maneuvering around obstacles.
Current recommendations for fall prevention guidelines in people with dementia are
limited.[23, 24] Unfortunately the strategies that successfully reduce falls in the cognitively
normal have not translated successfully to the cognitively impaired,[26] though there is
accumulating evidence of benefit in community-dwelling older adults with dementia[27].
Rehabilitation interventions to reduce fall risk can include individualized exercise programs and
the prescription of a mobility aid to compensate for deficits to allow maintenance of independent
ambulation. Possible explanations for the overall greater fall risk in people with dementia include
different underlying mechanisms, the magnitudes of association for risk factors that are shared
with cognitively normal older adults is greater and there may be unique risk factors that are not
present in cognitively normal adults. In addition to the development of new strategies, the
present study emphasizes we must also understand the impact of our current rehabilitation
interventions in order to develop programs that meet the unique health care needs of older adults
with dementia.
Impairment in executive function is associated with falls[7], and balance and gait
problems in older adults with and without a diagnosis of dementia [13,22,23]. This study also
demonstrated a significant relationship between executive function and walking, such that lower
scores on executive function were associated with longer times to complete each walking task.
As hypothesized, walking in a straight path without a walker had the lowest magnitude of
association to executive function and walking in a complex path with a walker had the highest.
Though the association was statistically significant, executive function only explained a small
amount of the variation in the time to complete the walk. As all people were new to using a
mobility aid, there may be a greater variation that was not explained by executive function in the
people with AD as a result of limited motor learning of a novel task creating anxiety of using
something unfamiliar and lower efficiency with execution of the movement. Further research is

warranted on the effects of training in people new to use of mobility aids and among people
experienced in using a mobility aid.
Difficulty maneuvering around obstacles can be a result of altered visuospatial abilities
and executive function, which combined with limited memory for retaining teaching of the safe
use of the equipment can pose a fall risk problem.[27, 28] The people with AD in this study had
a higher prevalence of vision problems than the cognitively healthy controls. Vision impairment
in depth perception and contrast sensitivity occurs in up to 60% of people with AD[30], these
changes can affect safe navigation around obstacles with a mobility aid and importantly also
increase cognitive load and therefore increase fall risk. The role of vision impairment in balance
and gait function among people with AD using a mobility aid has not been evaluated and merits
research.
It should be emphasized that the people with AD in this study were naïve to use of a
mobility aid and were not in need of using a mobility aid for ambulation. The study was to
evaluate the early learning effects of using an assistive device, independent of any functional
limitations that would usually necessitate a prescription for a walker. Future research should
focus on the timing of mobility aid prescription and the potential for learning effects with
repeated exposure to use of the equipment. It has been demonstrated that people with AD possess
intact implicit motor-learning capacities and therefore the potential for a reduction in cognitive
load while using a mobility aid is a possibility with training.[32]
There are several strengths to this study. Our samples were age and sex-matched to
remove these possible confounders as a source of any differences identified between the groups.
We were also able to perform several tests of cognitive function to provide a broad overview of
abilities between the groups. Additionally, all participants were able to complete the full
assessment protocol without loss of study participants. Some limitations to the study include we
did not include another manual task challenge for comparison, such as walking while carrying a
glass of water as a comparison of magnitude of cognitive load across different tasks. While a
sample size calculation was performed using data from other gait studies in people with
Alzheimer’s disease, the variation in scores was much greater than expected and may impact
magnitude of associations found in this study.
CONCLUSIONS
Ambulation with a wheeled walker, in particular maneuvering the walker around
obstacles, creates a greater attentional load in people with dementia than cognitively healthy
peers and presents a potential fall risk. In adults with dementia, the timing of gait aid prescription
to facilitate independent mobility may coincide with fragile brain function that cannot
accommodate greater resource utilization, ultimately leading to instability, unsafe use of the aid
and falls. Future research should explore the timing for safely introducing mobility aids among
people with AD and the role of improving executive function.
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Table 1. Demographic and clinical characteristics of study participants stratified by cognitive status.
Variable

Age in years (SD; range)

Older Adults
Controls
(n=14)
72.9 (9.5; 58-87)

Older Adults with
Dementia
(n=14)
72.6 (9.9; 57-85)

Female, n (%)

8 (57.1%)

8 (57.1%)

Years of education (SD; range)

15.1 (2.7; 12-21)

13.4 (2.6; 6-16)

0.10

Number of medications (SD; range)

1.8 (1.9; 0-5)

3.0 (2.5; 0-9)

0.15

Co-morbidities, n (%)
Hypertension

4 (28.6%)

3 (21.4%)

Diabetes

1 (7.1%)

1 (7.1%)

Osteoarthritis

4 (28.6%)

4 (28.6%)

Stroke/TIA

0 (0%)

3 (1%)

Vision problems

9 (64.3%)

12 (85.7%)

Cardiac problems

4 (28.6%)

3 (21.4%)

Activities of Daily Living
Lawton-Brody IADL (SD; range)

8 (0)

2.71 (2.27; 0-7)

<0.001

Lawton-Brody BADL (SD; range)

6 (0)

5.43 (0.94; 3-6)

0.032

Falls-related information

Group Comparison*
(p-value)
0.94

Falls in the last 12 months, n (%)

1 (7.1%)

2 (14.3%)

0.611

Fear of falling, n (%)

2 (14.3%)

4 (28.6%)

0.407

Falls Efficacy Scale (SD; range)

19.5 (4.0; 16-30)

19.3 (4.0; 16-31)

0.891

Physical activity level
Vigorously active, n (%)

13 (92.9%)

3 (21.4%)

<0.001

Moderately active, n (%)

1 (7.1%)

8 (57.1%)

Seldom active, n (%)

0 (0%)

3 (21.4%)

Cognitive Tests
MMSE (SD; range)

28.7 (1.6; 25-30)

18.6 (3.8; 12-25)

<0.001

Trail making test A (seconds)(SD; range)

39.6 (10.7; 25.3-67.3)

122.5 (79.6; 44.6-300.0)

<0.001

Trail making test B (seconds) (SD; range)

94.9 (56.1; 52.0-275.0)

232.8 (111.9; 110.0-436.0)

<0.001

*, group comparison using unpaired t-test, p<0.05 set as statistical significance; Vision problems, the total number of the presence of
cataracts, cataract surgery, macular degeneration; cardiac problems, the total number of the presence of myocardial infarction,
arrhythmia, atrial fibrillation; TIA, Transient Ischemic Attack; IADL, Instrumental Activities of Daily Living Scale; BADL, Basic
Activities of Daily Living Scale; MMSE, Mini-Mental State Examination; MoCA, Montreal-Cognitive Assessment.

Table 2. Time to complete and number of steps for the walking tasks of single task and
ambulation with a 4-wheeled walker in a straight and complex path configuration.
Task
Straight Path*
Time (sec)

Complex Path†
Time (sec)

Number of steps

Group
Control (n=14)
AD (n=14)

Single task

5.09 (0.76)

6.05 (1.26)

Wheeled walker

5.11 (0.95)

6.34 (1.58)

Single task

8.28 (2.45)

11.25 (4.87)

Wheeled walker

9.58 (1.81)

15.01 (5.60)

Single task

14.86 (2.28)

17.36 (5.85)

Wheeled walker

17.07 (1.77)

22.93 (7.25)

Values are means with S.D. in parentheses. *, main effect of group only was significant at
p<0.05 in ANOVA; †, interaction (group x task) was significant at p<0.05 in ANOVA for time
and number of steps. AD, Alzheimer disease group.

Table 3. Dual-task cost of ambulation with a 4-wheeled walker in a straight and complex path
configuration.

Straight path time

Dual-Task Cost (%)
Control (n=14)
AD (n=14)
- 0.53 (10.14)
- 4.64 (11.47)

Complex path time

- 19.7 (21.4)

- 38.1 (23.5)

Complex path number of steps

-16.85 (17.91)

-34.20 (19.61)

Values are means with S.D. in parentheses. Analyses were significant at p<0.05 for all between
group comparisons. Negative values indicate a slower time and an increase in the number of
steps while using the 4-wheeled walker.

Figure 1. The effect of single task walking and walking with a 4-wheeled walker on time to
complete a complex walking configuration in controls and people with Alzheimer’s disease
(AD).

Figure 2. The effect of single task walking and walking with a 4-wheeled walker on the number
of steps to complete a complex walking configuration in controls and people with Alzheimer’s
disease (AD).

Figure 3. Results of linear regression of association between the time to complete the Trail
Making Test-B (TMT-B) and the time to complete the gait tests as a single task and using a 4wheeled walker in a simple path (A) and complex path (B) configuration.
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